If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWalker Crips Regulatory News (WCW)

  • This share is currently suspended. It was suspended at a price of 13.50
  • There is currently no data for WCW

Disposal Update, Directorate Changes - Replacement

13 Apr 2012 10:15

RNS Number : 2893B
Walker Crips Group plc
13 April 2012
 



Please note that the announcement released on 13 April 2012 at 7.00 a.m. (RNS No: 2614B) was released with an incorrect company name for Mr Rushton's previous directorship. The correct company name is Endeavour Training Ltd. All other information within the announcement remains unchanged. The full corrected text appears below.

 

13 April 2012

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, TO US PERSONS, OR INTO THE UNITED STATES, OR INTO OR FROM CANADA OR ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL

WALKER CRIPS GROUP PLC

("Walker Crips" or the "Company")

Completion of the Disposal of WCAMandDirectorate Changes

 

Further to the announcement made on 5 April 2012, Walker Crips Group plc, the financial services group, is pleased to confirm that approval from the FSA has been received in respect of a change in controller of WCAM to Liontrust and that all remaining conditions to the SPA have now been satisfied. Accordingly, Completion has taken place.

As previously announced, Stephen Bailey has resigned from his position as a director of the Company effective immediately.

The Company is also pleased to announce the appointment of its Chief Investment Officer, Mark Justin Wells Rushton, to the Company's Board. Mr. Rushton, 49, will take up his additional executive responsibilities to the Board effective immediately.

In the last five years, Mr. Rushton has held the following directorships:

 

Current directorships

Previous directorships

None

Endeavour Training Ltd

There is no further information relating to Mr Rushton's appointment requiring disclosure under 9.6.13R of the Listing Rules.

The Company was notified on 10 April 2012 that Mark purchased 25,000 Ordinary Shares in the capital of the Company on 10 April 2012 at a price of 45p per Ordinary Share. Accordingly, as at the date of this announcement, Mark Rushton is interested in a total of 25,000 Ordinary Shares in the capital of the Company, representing an interest of 0.07 per cent. of the total voting rights of the Company.

 

For further information please contact:

Rodney FitzGerald, CEO

Walker Crips Group plc

www.wcgplc.co.uk

+44 (0) 20 3100 8000

Gordon NeillyRishi Zaveri

Canaccord Genuity Limited

www.canaccordgenuity.com

+44 (0) 20 7050 6778+44 (0) 20 7050 6780

Media enquiries:

Geri Jacks

Walker Crips Group plcwww.wcgplc.co.uk

+44 (0) 20 3100 8000

Notes:

Unless the context otherwise requires, defined terms used in this announcement shall have the meanings ascribed to them in the Company's circular to Shareholders dated 13 March 2012.

Canaccord Genuity Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as sponsor and financial adviser exclusively for the Company in connection with the Disposal. Canaccord Genuity Limited is not acting for any other person and will not be responsible to any other person for providing the protections afforded to clients of Canaccord Genuity Limited or for advising any other person in connection with the Disposal.

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUQUCUPPUBW
Date   Source Headline
25th Nov 20257:00 amRNSForm 8.3 - Walker Crips Group PLC
24th Nov 20257:47 amRNSDisclosure Table
24th Nov 20257:00 amRNSRecommended Cash Offer for Walker Crips Group PLC
24th Nov 20257:00 amRNSWorking Capital Loan Extension & Trading Update
29th Sep 20255:04 pmRNSResult of AGM
3rd Sep 20255:45 pmRNSDirectorate Change
14th Aug 20255:30 pmRNSDirectorate Change
31st Jul 20255:45 pmRNSWorking Capital Loan Drawdown Facility
31st Jul 20255:45 pmRNSFinal Results
9th Jul 20251:15 pmRNSBoard and Management Changes
28th Apr 20255:45 pmRNSAppointment of Non-Executive Director
7th Apr 202510:36 amRNSDirector Declaration
31st Mar 20255:45 pmRNSAppointment of Non-Executive Chairman
12th Feb 20254:32 pmRNSDirector Declaration
6th Feb 20255:45 pmRNSDirectorate Changes
27th Dec 20249:45 amRNSResults for the six months ended 30 September 2024
27th Nov 20247:30 amRNSDirector/PDMR Shareholding
27th Sep 202412:00 pmRNSResult of AGM
31st Jul 20241:00 pmRNSFinal results for the year ended 31 March 2024
14th Jun 202410:01 amRNSResignation of Non-executive Director
28th Dec 202312:15 pmRNSResults for the six months ended 30 September 2023
27th Sep 20232:07 pmRNSResult of AGM
31st Jul 20236:25 pmRNSFinal results for the year ended 31 March 2023
23rd Dec 202210:00 amRNSHalf-year Report
11th Oct 20225:19 pmRNSDirector/PDMR Shareholding
29th Sep 20221:37 pmRNSResult of AGM
29th Jul 20223:01 pmRNSFinal Results
9th Jun 20223:28 pmRNSHolding(s) in Company
26th Apr 20222:17 pmRNSDirector/PDMR Shareholding
29th Mar 20223:25 pmRNSDirector/PDMR Shareholding
16th Dec 20217:00 amRNSHalf-year Report
28th Sep 20211:12 pmRNSResult of AGM
16th Sep 20219:06 amRNSSecond Price Monitoring Extn
16th Sep 20219:00 amRNSPrice Monitoring Extension
20th Aug 20213:40 pmRNSFinal Results
28th Jan 20215:39 pmRNSDirector/PDMR Shareholding
27th Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 202112:03 pmRNSDirector/PDMR Shareholding
22nd Dec 20203:00 pmRNSExternal Auditor Appointment
27th Nov 20209:34 amRNSHalf-year Report - Replacement
27th Nov 20207:00 amRNSHalf-year Report
28th Oct 20209:24 amRNSDirector/PDMR Shareholding
2nd Oct 20203:55 pmRNSDirector/PDMR Shareholding
28th Sep 20207:00 amRNSDirector/PDMR Shareholding
18th Sep 20205:57 pmRNSDirector/PDMR Shareholding - Replacement
18th Sep 20204:48 pmRNSDirector/PDMR Shareholding
11th Sep 202010:01 amRNSDirector/PDMR Shareholding
9th Sep 202012:30 pmRNSResult of AGM
19th Aug 202012:25 pmRNSDirector/PDMR Shareholding
4th Aug 20202:59 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.